Peer Review History
| Original SubmissionDecember 17, 2021 |
|---|
|
PONE-D-21-39864IS MODULAR CONTROL RELATED TO FUNCTIONAL OUTCOMES IN INDIVIDUALS WITH KNEE OSTEOARTHRITIS AND FOLLOWING TOTAL KNEE ARTHROPLASTY?PLOS ONE Dear Dr. Siston, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 19 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Fatih Özden, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. Additional Editor Comments: Dear Authors, The reviewers has completed their comments. Please find their suggestion below. The manuscript should be revised regarding the comments. Reviewer 2 pointed out some important suggestions. King Regards. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Congratulations on the completion of your study and write up. Your study and findings on total knee arthroplasty and the factors that contribute to functional deficits post surgery are important and needed. Although your findings did not confirm your hypothesis, you still have good data that will contribute to the study, treatment, and practice of TKA. I recommend that this paper be accepted as it is free of errors, is written in standard English, has the data fully available, statistics are rigorous and appropriately performed, and the manuscript is technically sound. There are two suggestions I have to improve your manuscript and also future studies. 1) Line 184 it was not clear why there was a dramatic decrease in subjects. I would add to the sentence "due to attrition or by pilot study design etc.". This would answer my questions much more easily instead of having to dig into the discussion or results. 2) In future studies, it would be better to use BIA or DEXA instead of BMI to characterize body composition or describe your participants. BMI is not a measure of body composition but is used because of it's ease and tradition in medicine and science. It is really a very poor measurement. Since you were already testing the subjects for functional measures, what would it hurt to also do a quick BIA analysis? Nevertheless, well done on this study and the document. Reviewer #2: General comments This is a very well written and interesting paper, with proper statistical analyses. It investigated possible relationship between patient function and modular control during gait before and after total knee arthroplasty (TKA). Higher number of modules (muscle synergies) was associated to better performance-based and patient-reported function before and 6-months after surgery, although this was not verified 24-months after surgery. Moreover, results suggest that neuromuscular control strategies adopted before surgery are not permanent, which indicates that surgical intervention and rehabilitation have an influence on modular control strategy. The topic may be relevant to a large number of researchers and clinical personnel working in motor control, orthopedics and rehabilitation fields. That are, however, some points that can be improved. Here are my comments on that. The expression “36 participants (38 knees)” should be clarified. Moreover, authors should clarify how many participants repeated assessments and if some were not assessed before surgery but were assessed after. This is somehow plotted in Figures 3 and 4, but it would be easier for the reader to understand it if it was stated in the manuscript. Lines 72-74: “Once individuals can produce discrete neuromuscular control patterns, further improvements may present as improved module organization.”. What do authors mean with “discrete neuromuscular control”? In the third paragraph of the Introduction (lines 110-134), authors may also add the results reported in studies that investigated muscle synergies (motor modules) in related musculoskeletal conditions such as patellofemoral pain, which would help putting research in context. Lines 164-166. Peripheral Nerve Stimulation electrodes are not ideal for electromyography. Moreover, the European Project SENIAM (currently the gold standard for EMG recommendations) showed that circular electrodes with a diameter of 10 mm are preferred. Dimensions of the electrodes used in the current study are far larger and this should be mentioned. Tibialis anterior plays a crucial role during gait. EMG is usually recorded from this muscle during synergies analyses in gait and one of the synergies usually involves this muscle. Why did the authors decide to record other muscles with similar actions (e.g., lateral gastrocnemius and medial gastrocnemius) instead of using one of those EMG channels to record from tibialis anterior? Lines 273-275: “The muscle weights of each module for each participant at each timepoint were compared to the averaged weights of healthy age-matched controls with the same number of modules using Pearson correlations.”. If healthy subjects can have 2 of 3 modules, how can you validate the use of number of modules as a correlate of patient function? This should at least be discussed. This is also related with my previous point of recording from Tibialis anterior. Lines 358-367. What is the purpose of comparing tVAF from 1 to 8 synergies, if the number of extracted synergies was 2 or 3 synergies, depending on the subject? Figure 3. It is hard to check all individual values, but it seems that some subjects go from proper to improper module organization. I think this was not discussed. Section in lines 447-455. It could make sense to also describe results in terms of number of subjects that presented increased / decreased number of muscles, instead of just mentioning how many presented changes. Minor comments Lines 162-163: “Each participant performed a minimum of 5 over-ground walking trials.” There is no information on these trials: were they performed as overground walking or over a treadmill? Did the authors record heel strike moments or kinematics? How were beginning/end of strides detected? Line 163: Missing comma in 1,500 Hz. Line 165: Authors are encouraged to use the International System of Units (it should be cm or meters instead of inches). Line 193: “Trials with excessive motion artifact were excluded”. Please clarify how this was done. Line 196: “each trial contained 201 data points, accounting for every 0.5% of the gait cycle”. Please specify that each point corresponds to 0.5% of the gait cycle. Line 247: For those readers who are not familiar with the concepts of Wmusc and Wsum, please briefly explain how these values are calculated. What is the meaning of “clinically meaningful improvement”? Is this based on statistics (e.g., p-value < 0.01)? Line 447. Based on the title of line 384, maybe this title should be “Hypothesis II: Changes in Modules”. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
IS MODULAR CONTROL RELATED TO FUNCTIONAL OUTCOMES IN INDIVIDUALS WITH KNEE OSTEOARTHRITIS AND FOLLOWING TOTAL KNEE ARTHROPLASTY? PONE-D-21-39864R1 Dear Dr. Siston, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Fatih Özden, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): - Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for your clarification about my initial comments. I am satisfied with your efforts. Good luck with the publication. Reviewer #2: I want to thank the authors for addressing my previous comments. In my opinion, the current version of the manuscript makes a valuable contribution to the field. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Kathryn Rosie Lanphere Reviewer #2: No |
| Formally Accepted |
|
PONE-D-21-39864R1 Is modular control related to functional outcomes in individuals with knee osteoarthritis and following total knee arthroplasty? Dear Dr. Siston: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Fatih Özden Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .